Speaker Profile

Ph.D., Chief Operations Officer, Drawbridge Health, Inc.

Biography
Dr. Romeo oversees Research & Development, Manufacturing, and Regulatory activities at Drawbridge Health. She joined the company in late 2017, bringing her expertise and a wealth of experience in diagnostic test development for CLIA-certified, CAP-accredited commercial laboratories and medical device companies focused on in vitro diagnostic (IVD) test development. Prior to joining Drawbridge Health, Dr. Romeo served as VP of Research and Development at Gensignia Life Sciences, IVD Development Manager at Pathway Genomics, Associate Director of Operations at HistoRx and Principal Scientist at Genoptix. Dr. Romeo completed a post-doctoral fellowship at the Scripps Research Institute in La Jolla, CA and received her PhD in Biochemistry and Human Physiology from the University Zurich in Switzerland. She received her MS in Molecular Biology from the University of Insubria, Italy.


Clinical Dx Showcase:
Drawbridge Health, Inc.

Drawbridge Health exists for one overarching reason: to give everyone, everywhere access to the powerful health information within their own bodies. We are starting by reinventing the blood draw experience.

Blood Draw, Reimagined
Drawbridge Health has designed and developed the OneDraw™ A1C Test System, a blood collection device that is nearly painless, convenient, and easy-to-use, enabling the collection, stabilization, and transport of capillary blood samples to the laboratory for testing of HbA1c.

 Session Abstract – PMWC Silicon Valley


The PMWC 2020 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.